Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perispinal etanercept for chronic stroke-related fatigue and spasticity
ACTRN12620000912987Phase 2Completed
- Sponsor
- Griffith University
- Start
- Nov 2020
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of etanercept in stroke (2 arms), sponsored by Griffith University. Primary endpoints: Shoulder flexion and Fatigue Assessment Scale score. Started Nov 2020; status: completed.
02
Drugs
etanercept
03
Conditions
stroke
Beyond the preview
Go deeper on ACTRN12620000912987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000912987.